This is the authors' abstract. We don't add key points for this paper.
The angiogenic mechanism and therapeutic potential of PDGF-CC, a recently discovered member of the VEGF/ PDGF superfamily, remain incompletely characterized.Here we report that PDGF-CC mobilized endothelial progenitor cells in ischemic conditions; induced differentiation of bone marrow cells into ECs; and stimulated migration of ECs.Furthermore, PDGF-CC induced the differentiation of bone marrow cells into smooth muscle cells and stimulated their growth during vessel sprouting.Moreover, delivery of PDGF-CC enhanced postischemic revascularization of the heart and limb.Modulating the activity of PDGF-CC may provide novel opportunities for treating ischemic diseases.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Li et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: